Exparel (bupivacaine liposome) Injectable Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) December 2015 WARNINGS AND PRECAUTIONS Specific for EXPAREL Using EXPAREL followed by other bupivacaine formulations has not been...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts